Related Experiment Video
Updated: Aug 3, 2026
09:13
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Published on: November 1, 2011
[Experimental infection with hepatitis E virus in rhesus monkeys]
Z Li1
1Beijing viral Hepatitis Research Institute.
Zhonghua Yi Xue Za Zhi
|November 1, 1992
Summary
Researchers developed a hepatitis E virus (HEV) model in Rhesus Monkeys. Infected monkeys showed liver damage and HEV particles in stool, validating the model for studying the disease.
Area of Science:
- Hepatology
- Virology
- Primate Models
Context:
- Hepatitis E virus (HEV) infection is a significant global health concern.
- Establishing reliable animal models is crucial for understanding HEV pathogenesis and developing interventions.
- Rhesus monkeys offer a promising non-human primate model for studying human infectious diseases.
Purpose:
- To establish and characterize an experimental model of Hepatitis E in Rhesus Monkeys.
- To evaluate the pathological changes and viral shedding following HEV inoculation.
- To validate the use of Rhesus Monkeys as a model for HEV research.
Summary:
- Four Rhesus Monkeys were inoculated with Hepatitis E virus (HEV) from patient stool; two controls received PBS.
- Infected monkeys exhibited elevated ALT levels (3-4x normal) and characteristic liver pathology, including acidophilic degeneration and coagulative necrosis.
- Virus-like particles (27-34 nm) were identified in the stool of infected animals via immune electron microscopy (IEM).
Impact:
- This study successfully establishes a Rhesus Monkey model for Hepatitis E.
- The model demonstrates key pathological features and viral shedding consistent with human HEV infection.
- This primate model provides a valuable platform for future research into HEV therapeutics and vaccines.
